InnovAge Cash Flow Statement
NASDAQ: INNVHealth CareMedical/Nursing ServicesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
InnovAge free cash flow
In fiscal 2026, InnovAge generated $64.7 million of operating cash flow and spent $14.3 million on capital expenditures. That left free cash flow of $50.4 million, a free-cash-flow margin of 5.1% of revenue. Free cash flow was up 89.5% from the prior year's $26.6 million.
Summary generated from market data by MetaCap's automated system. Methodology
InnovAge cash flow statement (annual)
| Fiscal year (USD) | FY 20262026-06-30 | FY 20252025-06-30 | FY 20242024-06-30 | FY 20232023-06-30 | FY 20222022-06-30 | FY 20212021-06-30 | FY 20202020-06-30 |
|---|---|---|---|---|---|---|---|
| Net Income | -683.00K | -35.34M | -23.22M | -43.55M | -7.96M | -44.74M | 25.77M |
| Net Income growth (YoY) | — | — | — | — | — | -273.65% | — |
| Depreciation & Amortization | 21.14M | 19.51M | 18.95M | 15.42M | 13.92M | 12.29M | 11.29M |
| Stock-Based Compensation | 7.05M | 7.62M | 6.83M | 4.61M | 3.74M | 1.66M | 543.00K |
| Change in Working Capital | 29.60M | 27.60M | -57.78M | 39.82M | 3.21M | 7.03M | -3.27M |
| Operating Cash Flow | 64.71M | 32.87M | -36.90M | 20.24M | 27.30M | -7.55M | 43.83M |
| Capital Expenditures | -14.31M | -6.26M | -7.91M | -23.35M | -38.24M | -17.54M | -11.84M |
| Investing Cash Flow | -12.34M | -5.55M | -26.37M | -69.52M | -40.24M | -19.54M | -11.69M |
| Dividends Paid | — | — | — | — | — | -9.50M | — |
| Share Repurchases | — | — | — | — | — | -77.60M | — |
| Debt Issued | 60.08M | 0 | — | — | — | 375.00M | 25.00M |
| Debt Repaid | -71.28M | -3.80M | -3.79M | -3.79M | -3.79M | -512.66M | -1.93M |
| Financing Cash Flow | -18.53M | -19.08M | -7.03M | -7.90M | -6.32M | 116.22M | 21.23M |
| Net Change in Cash | 33.76M | 7.18M | -70.31M | -57.18M | -19.25M | 89.14M | 53.37M |
| Free Cash Flow | 50.41M | 26.60M | -44.81M | -3.12M | -10.94M | -25.09M | 31.98M |
This table shows 7 annual periods of InnovAge's cash flow statement, from FY 2026 back to FY 2020, across 14 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow INNV's reporting calendar. What is a cash flow statement?